Date: October 19, 2021
Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST)
Dr. Colleen Monaghan will present Hain Lifescience IVD workflows for the latest SARS-CoV-2 diagnostic assays. Rapid response to diagnostic capabilities is essential during these pandemic times. At Bruker-Hain a number of assays have been developed, including FluoroType® SARS-CoV-2 plus, FluoroType® SARS-CoV-2 varID Q, FluoroType® SARS-CoV-2/Flu/RSV, FluoroType® SARS-CoV-2 evo (RUO), which are essential to faciliate the continuous urgent response to the Covid-19 pandemic and for detection of variants in this highly dynamic situation. Accurate, reliable and efficient diagnostics are the essence of the Bruker-Hain offering. For this reason, we do not stop at the supply of world-leading assays but provide top-class instrumentation to ensure that the accuracy and efficiency is matched. The GenoXtract® fleXT is a fast, easy to use extraction device, which, with its PCR setup capabilities carefully balances the need for a maximum walk away time with flexibility of use and minimum hands-on time. Finally, the renowned FluoroCycler® XT, with simple, intuitive software, is easy to use and generates reliable and easy-to-interpret results.
Discover how your PCR workflow can be simplified by using automated extraction
Discuss the advantages of implementing FluoroType®, FluoroCycler® XT and GenoXtract® fleXT in your PCR workflow
Outline the SARS-CoV-2 FluoroType® assay product range
FluoroType® SARS-CoV-2 evo (RUO) is For Research Use Only. Not for use in clinical diagnostic procedures. All other mentioned products are IVD products and are not for sale in the USA. Please contact your local representative for availability in your country
Join us for our other webinars in this series:
Webinars will be available for unlimited on-demand viewing after live event.